Analyst Ranking
Top 3%
#146 out of 5278 analysts
Average Return
+22.04%
Win Rate
42%112 out of 266
Risk vs Reward
Poor
Good

Gregory Renza's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cidara Therapeutics IncCDTX
+1,088.30%$18.63$221.38
2025-05-08 -
2026-01-06
Buy
Cidara Therapeutics IncCDTX
+864.38%$22.88$220.65
2024-12-12 -
2025-12-12
Buy
Cidara Therapeutics IncCDTX
+811.78%$24.28$221.38
2025-05-22 -
2026-01-06
Buy
Prometheus Biosciences IncRXDX
+603.13%$27.52$193.50
2022-05-12 -
2023-04-18
Buy
Alpine Immune Sciences IncALPN
+428.30%$12.19$64.40
2023-10-04 -
2024-04-11
Buy

Gregory Renza Analyst Color

Get additional color on Gregory Renza's coverage of popular stocks

Gregory Renza's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cg Oncology IncCGON
8Strong Buy$82.00+22.52%Reiterates
2 days ago
Gilead Sciences IncGILD
4Strong Buy$157.00+21.16%Reiterates
8 days ago
Beone Medicines LtdONC
5Strong Buy$413.00+40.83%Reiterates
9 days ago
Amgen IncAMGN
20Hold$327.00+0.21%Maintains
15 days ago
Regeneron Pharmaceuticals IncREGN
5Strong Buy$796.00+14.00%Maintains
16 days ago
Agios Pharmaceuticals IncAGIO
9Strong Buy$36.00+27.80%Maintains
16 days ago
Viridian Therapeutics IncVRDN
14Strong Buy$33.00+96.20%Maintains
25 days ago
Ideaya Biosciences IncIDYA
14Strong Buy$60.00+112.69%Maintains
4 months ago
Fulcrum Therapeutics IncFULC
5Strong Buy$18.00+169.06%Maintains
5 months ago
Perspective Therapeutics IncCATX
7Strong Buy$12.00+211.69%Assumes
6 months ago
Nurix Therapeutics IncNRIX
12Strong Buy$30.00+89.21%Assumes
6 months ago
Xencor IncXNCR
10Strong Buy$29.00+158.47%Initiates Coverage On
6 months ago
Nuvation Bio IncNUVB
7Strong Buy$11.00+154.63%Initiates Coverage On
6 months ago
Nuvalent IncNUVL
1Strong Buy$140.00+36.85%Initiates Coverage On
6 months ago
Mannkind CorpMNKD
2Strong Buy$9.00+191.26%Initiates Coverage On
6 months ago
Bicycle Therapeutics PLCBCYC
4Hold$10.00+124.72%Initiates Coverage On
6 months ago
Ascentage Pharma Group InternationalAAPG
1Strong Buy$51.00+161.54%Initiates Coverage On
6 months ago
Abivax SaABVX
1Strong Buy$140.00+22.24%Initiates Coverage On
6 months ago
Exelixis IncEXEL
11Hold$50.00-0.26%Downgrades
10 months ago
Cidara Therapeutics IncCDTX
3Buy$35.00-84.19%Maintains
a year ago
Acadia Pharmaceuticals IncACAD
14Buy$26.00+21.50%Reiterates
a year ago
Adc Therapeutics SaADCT
12Buy$8.00N/AReiterates
a year ago
Inovio Pharmaceuticals IncINO
11Hold$5.00N/AReiterates
a year ago
Jazz Pharmaceuticals PLCJAZZ
14Buy$172.00N/AMaintains
a year ago
Spruce Biosciences IncSPRB
13Hold$0.50N/AMaintains
a year ago
Cormedix IncCRMD
6Buy$12.00N/AReiterates
a year ago
Verastem IncVSTM
10Buy$14.00N/AMaintains
a year ago
Pacira Biosciences IncPCRX
11Hold$18.00N/AReiterates
a year ago
Jasper Therapeutics IncJSPR
4Buy$48.00N/AMaintains
a year ago
Viracta Therapeutics IncVIRX
8Buy$2.00N/AMaintains
2 years ago
Verrica Pharmaceuticals IncVRCA
7Hold$20.00N/ADowngrades
2 years ago
Atyr Pharma IncATYR
7Buy$16.00N/AReiterates
2 years ago
Morphic Holding IncMORF
7Hold$57.00N/AReiterates
2 years ago
Alpine Immune Sciences IncALPN
4Hold$65.00N/ADowngrades
2 years ago
Fusion Pharmaceuticals IncFUSN
3Hold$21.00N/ADowngrades
2 years ago
Aptose Biosciences IncAPTOF
7Buy$540.00N/AMaintains
3 years ago
Avalo Therapeutics IncAVTX
4Hold$180.00N/ADowngrades
3 years ago
Bellus Health IncBLU
8Hold$14.75N/AReiterates
3 years ago
Prometheus Biosciences IncRXDX
6Hold$200.00N/AMaintains
3 years ago
Seagen IncSGEN
5Buy$229.00N/AMaintains
3 years ago
Global Blood Therapeutics IncGBT
3Hold$68.50N/ADowngrades
4 years ago
Aprea Therapeutics IncAPRE
5Hold$80.00N/AMaintains
4 years ago
Provention Bio IncPRVB
2Hold$10.00N/ADowngrades
5 years ago
Iterum Therapeutics PLCITRMF
3Hold$30.00N/ADowngrades
6 years ago
Portola Pharmaceuticals IncPTLA
1Buy$20.00N/AInitiates Coverage On
6 years ago
Arqule IncARQL
1Hold$20.00N/ADowngrades
6 years ago
Gamida Cell LtdGMDAQ
1Buy$20.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.